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Abstract 
Cobalamin is a coenzyme for S-adenosylmethionine methyltransferase and for 
methylmalonyl-CoA mutase which are involved in folate and propionic acid 
metaboUsm. Deficiency of cobalamin leads to the accumulation of methylmalonyi-CoA 
in body cells and subsequent elevation in the concentration of methylmalonic acid 
(MMA) in the blood circulation. Causes of cobalamin deficiency include malabsorption 
and insufficient dietary intake particularly in the elderly. Direct measurement of serum 
cobalamin is known not to be the most reliable method to identify cobalamin 
deficiency, but measurement of urinary MMA has been suggested to be sensitive. We 
attempted to assess cobalamin deficiency by measurement of urine MMA and to 
interpret its incidence in the elderly population, including vegetarian and non-
vegetarian. We established a gas chromatography mass fragmentography (GC-MS) 
method for the identification and quantitation of MMA after derivatization with N-
methyl-N-(tert-butyldimethylsilyl)trifluoroacetamide (MTBSTFA). The tert-
butyldimethylsilyl derivative was quantitated by selected-ion monitoring at mJz 403 and 
406 for methylmalonic acid and the internal standard, methyl-d3-mal0nic acid 
respectively . The linear regression equation for the nVz 403/406 ratio against MMA 
concentration was y = 0.3209 x + 0.0242, r = 0.999 (n = 7), y being the nVz 403/406 
- .• 
ratio and x being the concentration ofMMA in {imoL^. The lowest detection limit was 
0.12 pjnolyT .^ The within-run imprecision of low and high concentrations of MMA 
standards (3.4 and 12.4 ^mol/L) and MMA in urine sample (1.1 and 8.2 ^moUL) was 
less than 7 % and the between-run imprecision less than 8 %. The analytical recoveries 
ofMMA at three concentrations, 3.59, 8.2, 13.3 iimoUL, were 97.3, 94.8 and 89.6 % 
respectively. The linear equation in linearity study was y 二 0.3217 x + 0.0217, r = 1.00 
V 
(n = 16). The tert-butyldimethylsilyl derivative of MMA was stable at ambient 
• • 
temperature for at least one day. If an urinary MMA concentration of 5 ^imol/mmol 
creatinine was used as the cut-off value, then the cobalamin deficiency as indicated by 
urinary MMA excretion in the vegetarian and non-vegetarian elderly would be 19.3 % 
and 4.8 % respectively. There was also an increase in urinary MMA excretion with 
age. We find this GC-MS method for measurement of urinary MMA to be specific, 
reiiabie and sensitive as a routine test for the detection of cobalamin deficiency. Our 
results also suggested the vegetarian diet to be a causative factor for cobalamin 
deficiency in the local elderly population. 
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1.1 Biochemistry of cobalamin 
CrystalUne cobalamin was isolated in 1948 and its three dimensional structure 
was subsequently elucidated by Hodgkin et al using X-ray crystallography. 
Cobalamin is a corrinoid compound with a corrin ring which is a macrocyciic 
ring formed by four reduced pyrrole subrings bound to a central cobalt atom. The 
attachment of different anionic group ligands to the cobalt atom above the plane of the 
corrin nucleus results in four common forms of the cobalamins : cyanocobalamin (CN-
cbl), methylcobalamin (Me-cbl), adenosylcobalamin (Ado-cbl) & hydroxocobalamin 
(OH-cbl) [1]. Beneath the plane of the corrin ring is a complex side-chain consisting of 
a 5,6-dimethylberizimidazole group, a ribose molecule and a phosphate moiety. The 
benzimidazole is linked to the cobalt atom through one of its nitrogen atoms, while the 
phosphate is bonded to the D member of the corrin ring. CN-cbl is a synthetic 
compound and does not occur naturally in biological systems. However, OH-cbl, Ado-
cbl and Me-cbl can be isolated from animal tissues such as liver and kidney. Me-cbl 
and Ado-cbl are the only two forms of cobalamin known to act as specific co-enzymes 
in the metabolism of folic acid and propionic acid. Fig. 1 shows the chemical structure 
ofcobalamin. 
1.1.1 Biological functions of Coba!amia 
In peripheral blood, cobalamin is in the hydroxyl form (OH-cbl) transported to 
target cells by a protein carrier, transcobalamin H (TC-H). On reaching the cell 
membrane, the whole hydroxocobalamin-transcobalamin II (OH-cbL^TC-H) complex is 
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Fig.l Chemical structure of cobalamins (Ayalew Tefferi et al. Mayo 
ClinProc 1994, 69:181-186). 
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release the OH-cbl. Some OH-cbl is converted to Me-cbl. Some is carried into the 
nucleus where it is reduced to form Ado-cbl. Fig. 2 shows the cellular pathway and 
compartmentation of cobalamin in a mammalian ceU. Me-cbl is a coenzyme for S-
adenosylmethionine methyltransferase. Li foUc acid metabolism, Me-cbl catalyzes the 
methylation of homocysteine to methionine coupled with the transformation of 
metabolically inactive 5-methyl-tetrahydrofolate to active tetrahydrofolate (FH4). FH4 
is then converted to the folate coenzyme N '^^ ^-methylene FH4 which is required for the 
integration of thymidine into DNA. On the other hand, Ado-cbl is the coenzyme for 
Ado-cbl mutase. In the metabolism of propionic acid, Ado-cbl mutase catalyzes the 
isomerization of methylmalonyl-CoA to succinyl-CoA [2,3]. 
1.1.2 Causes of Cobalamin deficiency 
Only micro-organisms are known to produce cobalamin. The dietary source of 
cobalamin for mammals is animal products. The daily requirement of cobalamin is 
about one microgram for an average man [4]. Many conditions can lead to cobalamin 
deficiency. 
Deficiency of intrinsic factor (DF) is a common cause, making absorption of 
cobalamin through the gastrointestinal tract impossible. EF is a glycoprotein produced 
by the gastric parietal cells. In the stomach, cobalamin binds with R proteins and 正. 
The R proteins are named owing to their rapid movement on electrophoresis [5]. In the 
duodenum, pancreatic proteases degrade the R proteins but not the JF. As a result, all 
cobalamin can be bound to JF. The EF-cbl complex travels through the small intestinal 
tract. At the distal portion of the ileum, the complex is absorbed while the 
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Fig.2 General pathway of the cellular uptake and subcellular compartmentation 
of cobalamins and of the intracellular distribution and enzymatic synthesis of 
cobalamin coenzyme, TCDL = transcobalamin H, OH-cbl = hydroxocobalamin, 
Me-cbl = methylcobalamin, Ado-cbl = adenosylcobaiamin, cbP^ cbl", cbl^,= 
cobalamins with cobalt valence of3+，2+ & 1+ respectively.(From Charles RS et al, 
The metabolic and molecular basis of inherited disease 7 th Ed, P.1430.) 
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whole free fraction of cobalamin is non-absorbable. When the amount ofIF secreted in 
the stomach is low, cobalamin absorption would be insufficient [6]. 
Another cause is deficiency of gastric acid. The prerequisite for release of 
cobalamin from its protein-bound state i§ an acidic environment in the stomach. In 
conditions such as achlorhydria, peptic digestion is inadequate. Cobalamin cannot be 
released from the binding protein. Achlorhydria is common in the elderly people and 
may iead to malabsorption ofcobaiamin. 
Malabsorption of the intrinsic factor-cobalamin complex (EF-cbl) across the 
mucosa in the ileum is another cause. The EF-cbl complex must bind to specific 
receptors located in the mucosa in the terminal portion of the ileum. Calcium ion, 
magnesium ion and an alkaline medium are required for the binding. Any disruption in 
the receptor binding of the BF-cbl complex may lead to malabsorption of cobalamin. 
Common causes include mucosal damage, bacterial over-growth in the intestine, 
infestation by the fish tapeworm, severe pancreatic disease and interference by certain 
drugs such as trichloracetic acid [7]. 
Finally, cobalamin deficiency may be due to diet. Animal food products are 
generally rich in cobalamin. OH-cbl and Ado-cbl are abundant in meat while dairy 
products have more OH-cbl and Me-cbl. Insufficient intake of such food products may 
result in cobalamin deficiency. Individuals at risk of cobalamin deficiency include 
lactating women consuming vegetarian diet [8,9,10], elderly people [11] and 
vegetarians not taking diary products [ 12,13]. 
6 
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1.1.3 Significances of cobalamin deficiency 
In mammalian cells, absence of the coenzyme Me-cbl leads to decrease in the 
activity of N^-methyltetrahydrofolate:homocysteine methyltransferase which is 
involved in the synthesis of methionine and tetrahydrofolate[ 14]. The disruption of 
methionine formation leads to the cessation of folate cycle with accumulation of 
methyltetrahydrofolate and ultimately functional foiate deficiency. Since folate 
metabolism is involved in the synthesis of KN"A and DNA, cobalamin deficiency will 
lead to impaired nucleic acid synthesis and hence the possible development of 
megaloblastic anaemia [15]. In the early state, megaloblastic changes include elevated 
MCV, slight enlargement ofRBC precursors and peculiar sieve-like appearance of the 
nuclear chromatin. If such conditions persists, leucopenia, thrombocytopenia and 
macrocytes with considerable anisocytosis and poikilocytosis will be found in the 
peripheral blood. In addition, abnormally large metamyelocytes and band neutrophils 
may be seen in the bone marrow. Hypersegmented polymorphonuclear neutrophils are 
also characteristically found in the peripheral blood. 
Since homocysteine, methionine, S-adenosylhomocysteine and S-
adenosylmethionine are involved in trans-methylation reaction, polyamine synthesis and 
enzyme regulation in the central nervous system, cobalamin deficiency can interrupt the 
interconversion of these compounds, causing permanent neurologic disability such as 
subacute combined degeneration of the spinal cord [16] and mental changes. The onset 
ofneurological symptoms is insidious. Impaired vibration sense is found to be the most 
common feature followed by paresthesia, impaired position sense, ataxia, abnormal 
gait, memory loss, weakness of the limbs, depression, disorientation or even sexual 
impotence in males [17]. Moreover, the atypical presentation is similar to other 
7 
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diseases such as early stage Alzheimer's disease [18,19]. If such patients are not 
treated appropriately, these neurologic changes are irreversible and may be followed by 
significant abnormalities of blood cells in the peripheral blood [20]. However, most 
neurologic deficits can be resolved even if cobalamin treatment is started three to six 
months after the onset ofdisease [21]. 
1.1.4 Assessment of cobalamin deficiency 
Patients classified as cobalamin deficient have the following abnormalities [22]: 
(1) serum cobalamin concentration is less than 150 pmoH.； 
(2) red blood cell MCV is greater than 99 fL ； 
(3) segmented neutrophil lobe count is greater than3.6/cell ； 
(4) Schilling test is abnormal. 
Cobalamin deficiency can be determined by measurement of serum cobalamin 
concentration. However such measurement has been shown to be inaccurate to reflect 
the intracellular cobalamin concentration [11,23,24,25]. True cobalamin deficiency 
might have high serum cobalamin concentration [26], Some healthy individuals with 
low serum cobalamin concentration show no signs and symptoms of cobalamin 
deficiency [27]. Many clinical and analytical factors can affect the serum cobalamin 
concentration. Clinical conditions such as transcobalamin (TC-H) deficiency and 
myeloproliferative disorders may be associated with normal serum cobalamin 
concentration [28,29]. Other conditions such as multiple myeloma and acquired 




Analytically, measurement of serum cobalamin by RIA is subject to the artefact 
caused by the presence of binding protein. In the radioimmunoassay, radioactivity due 
to the presence of radiolabelled cobalamin analogs in the bound fraction shows an 
inverse relationship with the serum cobalamin concentration [32]. Binding proteins 
might be present in the intrinsic factor (正）preparation which was supplied 
commerciaUy. They could bind both biologically active cobalamin and radiolabelled 
cobaiamin analogs. During the reaction, these binding proteins may compete with the 
JF for the radiolabelled cobalamin. If the binding of cobalamin analogs with 正 is 
reduced, then the radioactivity in the bound fraction would be decreased. 
Consequently, the measured value of serum cobalamin will be elevated. In severe liver 
disease or myeloproliferative disorders with lucocytosis, the cobalamin binding protein 
level is elevated and the measured cobalamin concentration will be falsely high. Other 
interferences included chloral hydrate and cyanide [33,34,35]. Choral hydrate over-
dosage can cause falsely high serum cobalamin concentration when measured by 
radioimmunoassay. The actual cause for such inaccurate measurement is not known, 
although chloral hydrate might interfere with the binding of JF with cobalamin in 
radioimmunoassay. Potassium cyanide is used for alkaline denaturation of endogenous 
proteins present in the sample. Cyanide at an acidic pH may convert inactive cobalamin 
analogs into CN-cbl which gives a positive reaction. Falsely high serum cobalamin 
concentration can be obtained even though the true serum cobalamin concentration is 
low [36]. Therefore, serum cobalamin level is not a reliable index for cobalamin 
deficiency [5,20,37,38]. 
The red cell mean corpuscular volume (MCV) index is also not a reliable 
diagnostic test for cobalamin deficiency. MCV is typically elevated in megaloblastic 
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anaemia. However, many patients with pernicious anaemia and borderline low 
cobalamin concentration have MCV in the upper normal reference range [5]. 
The number of hypersegmented polymorphonuclear neutrophils in peripheral 
blood may be used as an index of cobalamin deficiency [17]. However, their numbers 
in the peripheral blood may be small. It may be difficult to distinguish true 
hypersegmentation (five lobes or more) from normal individual variation. Furthermore, 
segmented neutrophil iobe count is subject to human and analytical errors. 
The Schilling test is a test for both gastric and intestinal function, indirectly 
assessing the absorption of cobalamin from the small intestine. It is performed by 
applying an oral dose of radiolabelled cobalamin followed by an non-radiolabelled 
cobalamin dose via intramuscular injection [5]. The amount of radiolabelled cobalamin 
excretion in the urine is determined as a percentage ofthe original dose. This method is 
lengthy, labour intensive and involves radioactive tracer. It is also affected by 
incomplete urine collection, depressed urinary excretion of cobalamin in diabetes, renal 
diseases, hypothyroidism, old age and enteritis [5]. 
The predictive value of serum cobalamin measurement for the diagnosis of 
cobalamin deficiency had been estimated to be 22.2 % [37]. To justify a long term 
parenteral therapy or to differentiate other conditions from cobalamin deficiency, low 
serum cobalamin concentration is not a good criterion. Assessment of tissue deficiency 
of cobalamin is regarded to be more reliable than serum cobalamin measurement [38]. 
1.2 Biochemistry of Methylmalonic acid (MMA) 
Methylmalonic acid (MMA), MW = 118，is a saturated short chain dicarboxylic 
acid. It is the breakdown product of methylmalonyl-CoA. Methylmalonyl-CoA is the 
1 0 
intracellular precursor in the metabolic pathways for several amino acids (valine, 
isoleucine, leucine, threonine and methionine), odd-chain fatty acids, cholesterol and 
thymidine [39]. The structure is as follows : 
H 
I 
HO - C - C - C - OH 
II W 
0 0 
1.2.1 Elevation of MMA in biological fluids 
Ado-cbl is a cofactor required for the isomerization of methylmalonyl-CoA to 
succinyl-CoA catalysed by Ado-cbl mutase. When the serum OH-cbl level is low, the 
tissue cofactors, Me-cbl and Ado-cbl, will also be low in concentration. As a 
consequence, Ado-cbl deficiency will cause the isomerization to be blocked and 
methylmalonyl-CoA accumulates intracellularly. Subsequently, methylmalonyl-CoA is 
degraded by methylmalonyl-CoA hydrolase to CoA and methylmalonic acid (MMA). 
The MMA so formed is released into the blood circulation and is excreted in urine 
[40]. Both serum MMA and urinary MMA will be increased in cobalamin deficiency. 
1.2.2 Significances of measurement of MMA 
Both the folate-dependent conversion of homocysteine to methionine and the 
folate-independent conversion of methylmalonyl-CoA to succinyl-CoA require 
cobalamin. Therefore, homocysteine ^Hcy) and MMA will accumulate in blood in 
i 
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cobalamin deficiency. Their serum concentrations indicate the availability of cobalamin 
for the tissues. In one report, both concentrations of MMA and homocysteine were 
found to be increased in 96 % of patients with cobalamin deficiency [20]. Since serum 
homocysteine concentration will also increase in folate deficiency, serum MMA is 
more specific for cobalamin deficiency. However, the specificity of serum MMA is 
affected by such conditions as renal failure, dehydration or the metabolic activity ofthe 
gut flora [41,42]. Serum MMA concentration will be elevated in renal failure. In case 
of dehydration, volume depletion will raise serum MMA concentration. Disturbance of 
propionate production by gut flora alteration will reduce semm MMA concentration. 
Determination of urinary MMA level is a non-invasive test. It is more practical 
and more sensitive for detecting tissue cobalamin deficiency than is the measurement of 
the MMA in serum. Another advantage is that urinary MMA concentrations are 
normalized by creatinine concentration, and thus there is correction for renal 
insufficiency and dehydration [43]. In a screening study on an elderly population for 
cobalamin deficiency, 4.4 % of 809 elderly people was found to have elevated urinary 
MMA concentration [21]. Further clinical assessment and subsequent cobalamin 
therapy of those subjects confirmed cobalamin deficiency. It was also revealed that 
only 60 % of the patients with increased urinary MMA values had abnormally low 
serum cobalamin concentration. Moreover, Yamauchi et al found that patients with 
neurologic disturbances excreted larger amounts of MMA than those without 
neurologic disorders [44]. MMA could be a useful adjunct to distinguish megaloblastic 
anaemia from myelodyplasia with megaloblastosis [44]. 
1 2 
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1.2.3 Methods of measurement of urinary MMA 
(a) Paper Chromatography 
Two-dimensional chromatography of urinary MMA followed by bromocresol 
green staining provided a semi-quantitative method of measurement [45]. Urine was 
acidified and extracted with ether. It may be a crude method but is still useful 
particularly when sophisticated equipments are not available. 
(b) Spectrophotometric method 
Acidified urine was first saturated with ammonium sulphate and extracted with 
ethanolic ether [46]. MMA in the extract was past through a column of strongly basic 
ion exchange resin and eluted with hydrochloric acid. MMA was detected by a reaction 
with p-nitroaniline. This method is non-specific and MMA measurement may be 
interfered by other endogenous substances in the urine sample such as propionic acid, 
acetoacetate, urate, creatinine, ascorbate and malonate. Moreover, the sensitivity was 
low. 
(c) Gas Chromatography 
MMA could be decarboxylated at 225 °C to propionic acid and analysed by gas 
chromatography using flame ionization detection (GC-FE3) [47]. Endogenous 
propionic acid was first quantitated by measurement at lower temperatures (130°C) at 
which the methylmalonic acid would not be decarboxylated. This method measured 
MMA indirectly and was subject to strong interference by endogenous propionic acid 
and affected by the efficiency ofMMA decarboxylation. 
1 3 
(d) Enzymatic method 
The principle was based upon the coenzyme A conversion of propionic acid by 
acetyl-CoA synthetase isolated from baker's yeast. MMA was decarboxylated by heat 
to propionate indirectly. Acetyl-CoA synthetase catalysed the conversion of acetate or 
propionate to acetyl-CoA or propionyl-CoA [48]. The propionyl-CoA was determined 
by the carnitine acyl-transferase reaction and measurement of resultant CoA by a 
chromogen reaction with 5,5‘dithiobis-(2-nitrobenzoic acid) ^)TNB) to form the 
nitrobenzoic derivative. The optical density was measured at 412 nm. A drawback of 
this method is that the presence of acetate and endogenous propionic acid might cause 
over-estimation ofMMA. Moreover, complete decarboxylation ofMMA might not be 
attained. 
(e) High performance liquid chromatography 
This technique employed organic solvent extraction of MMA from urine by 
ether and derivatization with monodansylcadaverine, followed by high performance 
liquid chromatography analysis ofthe dansyl-MMA derivatives by visible spectrometry 
[49]. This technique was not sensitive enough for serum MMA measurement. 
(f) Gas chromatography mass spectrometry 
Norman et al identified and quantitated urinary MMA as its dicyclohexyl ester 
by GC-MS [50]. MMA in urine was derivatized to form the dicyclohexyl and 
quantitated using a Finningan 9500 chromatograph interfaced to a Finningan 3200 
mass spectrometer with selective ion monitoring (SB4) capability. The dicyclohexyl 
1 4 
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derivatives were very stable. However, there was an interference peak that affected the 
signals of the d3-MMA intemal standard. 
In a GC-MS method by Marcell et al [51], the intemal standards used were 
[methyl-i4c] methylmalonic acid and [l,4-^^C2] succinic acid. MMA in urine or serum 
was extracted by diethyl ether and purified by anion-exchange chromatography. For 
GC-MS analysis, the MMA residue was derivatized with N-methyl-N-(tert-
butyidimethyisiiyi)trifiuoroacetamide, MTB STFA, to form tert-butyldimethylsilyl 
esters. The MMA was quantitated by monitoring the integrated areas of m/z 289.2 
peak (MMA) and 292.2 peak (d3-MMA). This method involved purification ofMMA 
by anion-exchange. The process was time consuming. Another shortcoming of this 
method was that the relative molecular mass of the monitored ions for MMA and d3-
MMA were less than 300. There might be interference by ion peaks of small ion 
masses. 
In another method, d3-MMA was used as the intemal standard and MMA in 
acidified urine was extracted with ethyl acetate[18]. The MMA residue was derivatized 
directly with MTBSTFA prior to GC-MS. The ion at m/z ratio 289 for MMA and 292 
for intemal standard was monitored by SJM mode. This method was relatively simple. 
The assay was shown to be highly reproducible with imprecision less than 4 %. The 
detection limit was below 0.85 p,mol>T^ . The drawback of this method was that the 
relative molecular mass of the monitored ions was low. Unknown substance might 
produce interfering ions with the same molecular weight. 
Therefore, a reference method with simplicity, specificity and good 






(A) To establish a method for analysis of urinary MMA by gas chromatography mass 
spectrometry. The analytical performance of the method will be assessed. 
Q3) To study the relationships between urinary MMA excretion and old age and 
between urinary MMA excretion and serum cobalamin. 
(C) To compare urinary MMA excretion in two groups of elderly subjects, vegetarian 
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3.1 Study subjects 
Both male and female elderly subjects (vegetarian and non-vegetarian) were 
recruited from old-aged homes, hostels and Prince of Wales Hospital between 
December 1994 and August 1995. The age of all subjects was equal to or greater than 
60 years. 
3.2 Sample collection 
Specimens of moming fasting urine were collected into plain bottle. Fasting 
whole blood specimen were drawn by venipuncture to obtain serum and heparin 
plasma. An aliquot of urine was taken immediately for creatinine measurement. The 
serum and urine specimens were stored at -20°C for not more than two months prior to 
analysis for MMA and cobalamin respectively. 
3.3 Biochemical and haematological analysis 
Biochemical tests were carried out on the plasma specimens immediately and 
they included the liver function tests (total protein, albumin, total bilirubin, alkaline 
phosphatase, alanine transaminase, aspartate transaminase and gamma glutamyl 
transaminase), renal function tests (sodium, potassium, urea and creatinine), thyroid 
function test ( sensitive thyroid stimulating hormone), bone profiles (total calcium and 
phosphate) and trace elements (zinc and copper). Serum was used for the measurement 
of iron profiles (serum iron, total iron binding capacity and percentage of saturation). 
The liver function tests, renal function tests and bone profiles were 
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\ 
carried out on a Dimension autoanalyser (Dupont, Willmington, USA) with classical 
colorimetric methods. The thyroid function test was carried out by using the ACS:180 
• 
autoanalyser (Ciba-Coming Diagnostics Corp., Medfield, MA) with a 
'chemiluminescent immunoassay (CIA) method. The iron profiles were performed on a 
Cobas-Bio centrifugal analyser (Roche Analytical Instruments Inc, Basle, Switzerland) 
with a colorimetric method by the formation of colour complex between iron (II) ions 
and ferrozin. Trace elements were assayed by using the Varian AA-1475 series atomic 
absorption spectrophotometer (Varian Techtron Pty. Limited, Mulgrave, Australia). 
This method was based on absorbance ofthe element in the fumace. The concentration 
ofthe analyte was derived from a calibration curve. 
Whole blood analysis for red cell counts, white cell counts, haemoglobin 
content and mean cell volume were assessed. The blood counts were performed by 
using Coulter autoanalyzer (Coulter Electronics, Inc., Hialeah and Oakville, Ont. 
Canada). 
All these laboratory tests were carried out on blood samples obtained from 
vegetarians only. Blood samples from non-vegetarians were randomly checked. 
3.4 Measurement ofurinary creatinine concentrations 
Creatinine concentration in urine was determined by the Jaffe' reaction (kinetic) 
without deproteinization on a Hitachi 911 autoanalyser (Boehringer Mannheim, 
Mannheim, W. Germany). The procedure involved measurement of the rate of 




3.5 Measurement of serum cobalamin concentration 
Serum cobalamin concentration was assayed by a radioimmunoassay, the Solid 
Phase No Boil Dualcount with radioisotopes "Co and ^^ 1^ from Diagnostic Products 
corporation QLos Angeles, CA, USA). This method could measure serum cobalamin 
and folic acid simultaneously. Sample pretreatment involved three steps in this DPC 
assay system: alkaline denaturation of endogenous proteins, competition for purified 
binder at pH 9.3 and solid phase separation. 
Cobalamin in serum was released from carrier proteins by incubation at high 
pH, above 12, in the presence of dithiothreitol and^  potassium cyanide. The antibodies 
of intrinsic factor and even cobalamin transport proteins at very low concentrations 
were inactivated under these conditions. 
Purified hog TF was employed as the binder for cobalamin. Analogs did not 
interfere because the binder was free of receptor proteins. Moreover, the reaction took 
place at a pH where IF was fully active. The binder was immobilized on 
microcrystalline cellulose particles. The bound fraction of the ^^Co-cobalamin 
radioisotope was isolated from the unbound fraction by centrifugation. The unbound 
fraction was removed by aspiration. 
Radioactivity (counts per minute) due to ^^Co-cobalamin in the bound fraction 
was detected by a gamma counter. Logit-log representation of the radioactivity was 
then transformed into cobalamin concentration by comparison with a calibration curve. 




3.6 GC-MS determination of urinary MMA 
The measurements of urinary MMA and serum cobalamin were carried out 
independently. They were double bUnd tests. 
Urinary MMA was measured by a stable isotope dilution method using d3-
MMA as the internal standard. During sample preparation, any loss of MMA were 
matched exactly by loss in intemal standard. 
Li the assay, standard mixture of MMA and d3-MMA were derivatised with 
MTBSTFA and analysed by GC-MS. The ions of m/z ratios 403 and 406，which were 
derived by the loss of a C H 3 O group from the parent ions, were characteristic of 
molecular ions of the analyte MMA and the intemal standard d3-MMA respectively. 
The mass spectrometer monitored the ions simultaneously. The resulting selected ion 
monitoring {SJM) chromatograms were similar to the conventional gas 
chromatograms. A standard curve was derived from the response ratio of m/z 
403/406. The concentrations of MMA in urine were calculated by converting the 
response ratio to quantities ofMMA in the standard curve. 
3.6.1 Equipments 
A Hewlett-Packard OPalo Alto. CA, USA) Model 5880 was equipped with a 
fused silica-capillary column (HP.1 GC column，25m X 0.25mm X 0.33^im thickness) 
in a oven, an chemstation that was interfaced to a Hewlett-Packard Model 5970A 
selective detector with total ion monitoring (TBV1) and selected ion monitoring (SDvl) 
modes. The injection port, transfer line and source temperatures were maintained at 
240, 250 & 220 °C respectively. Helium gas (99.995 % pure，Hong 
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Kong Oxygen & Acetylene Co., Clearwater Bay, Hong Kong) was used as the carrier 
gas. The split ratio of inlet flow to column flow was 15:1. The GC-MS was equipped 
with a HP 7673 GC/SFC autoinjector. The mass selective detector was tuned with 
perfiuorotributylamine fPFTBA) as the calibrator on an automatic mode. 
MMA was quantified by selected ion monitoring (SEVQ mode, in which the 
quadruple mass filter (QMF) was programmed to select ions at m/z 403 and 406. The 
SDvl mode improved the analytical sensitivity of the assay because the selected ions 
rather than whole ion chromatogram with many signals were focused on. Furthermore, 
a shorter cycle time by SJM mode allowed a GC peak to be sampled more often so that 
quantitation was more accurate. 
3.6.2 Chemicals 
2-Methyl-propanedioic acid (MMA) was from Sigma (St. Louis, MO, USA). 
d3-MMA, 999.46%-d3, was obtained from CAD/N isotopes Inc. (Vaudreuil，Quebec, 
Canada). Ethyl acetate and hydrochloric acid (37 %)，were from Merck (Darmstadt, 
FRG). Perfiuorotributylamine (PFTBA) from Hewlett Packard was used as the 
calibrator for mass spectrometry. N-methyl-N-(tert-butyldimethylsilyl) 
trifluoroacetamide (MTBSTFA) and dimethylformamide fDMF) of silylation grade, were 
from Pierce (Rockford, JL, USA). 
3.6.3 Preparation of Reagents 
The stock MMA and d3-MMA solutions were at 200 mg/L. The working 





400 ng of d3-MMA (20 fiL，20 mg/1 )^ was spiked into one mL of an urine 
specimen or aqueous medium. The mixture was adjusted to pH 1 by addition of about 
20 fjJL concentrated hydrochloric acid (37 %). Sodium chloride (about 100 mg) was 
added until saturation. To the mixture, 3 mL of ethyl acetate was added, vortexed and 
centrifjged at 4000 rpm for 5 minutes. This extraction was repeated three times and 
the ethyl acetate extracts were pooled and blown to dryness gently in a stream of 
nitrogen gas. This extraction procedure was modified from a published method [52". 
3.6.5 Derivatization 
The derivatizing agent was freshly prepared by mixing equal volumes of 
MTBSTFA (40 [jJJ) and DMF (40 i^L). The MMA residue for the extract was mixed 
with 80 [jJu of the derivatizing agent and incubated at 80°C for one hour. After 
derivatization, the sample, was transferred to a three-prod mini-vial (100 f^ iL) for 
injection into the gas chromatography -mass spectrometry (GC-MS) system. The 
derivatization conditions were modified from a published method [53]. 
3.6.6 GC-MS analysis 
One pL of sample, control or standard was injected. The temperature program 
parameters were modified according to the GC-MS method by Marcell et al [51]. Four 
temperature program rates，4，6，8 and 10 °C/min, had been tested. It was found that 
the retention time ofMMA peak was 32 minutes when the temperature program rate 
was 4 °C/min. The MMA peak showed up at 21 minutes when the temperature 
23 
、. 
^^ ^^ ^^ ^^ ^^ ^^ ^^ ^MM^^ ^Hi^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ HI^ ^^ H^^ ^^ ^^ H^^ ^^ ^^ ^^ HHII^ ^H^^ ^^ ^^ ^^ ^H^^ ^^ ^^ ^HIH^HHI^ H^^ raBraBMBHHI^ mmssannra 
program rate was 6 °C/min. To increase the temperature program rate to 8 °C/min, the 
retention time o f M M A peak was 13.5 minutes. When the rate was 10 °C/min, the 
MMA peak appeared at 13.1 minutes. However, a shorter running time at higher 
temperature program rate was accompanied by a higher noise signal. The noise signal 
at the temperature program rate of 8°C/min was analytically acceptable. The oven 
temperature was programmed from 130�C to 260�C. The retention time of the 
measured ions ranged from 12.66 to 12.68 minutes. The final GC-MS protocol was 
shown in Table 1. 
3.7 Statistical analysis 
The computer software, Microsoft Excel version 5.0 from Microsoft 
Corporation, was utilised to calculate the means (X), standard deviation (SD), 
coefficient of variation (CV) of urinary MMA concentration and serum cobalamin 
concentration. The effects of age and diet on urinary MMA excretion were examined 
by linear regression analysis using the least squares method.. The standard Student's t 
test techniques were used for paired data and unpaired data analysis. The averages 
quoted were expressed as mean value 土 1 standard deviation, X 土 SD，udess 
otherwise indicated. The p values referred to two-tailed tests. Chi-square Test with 
Yates correction was used. 
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Table 1 Final GC-MS Protocol 
The foUowing parameters were used in this study. The total run time for each 
chromatographic analysis was 30 minutes. 
(A) Data Acquisition 
a) Parameter File D3MMA.A 
b) Tune File *ATUNE.U 
c) Acquisition Mode SJM 
d) Inlet GC 
e) PrintOut Destination PEJNTER 
(B) Temperature Program Parameters 
a) Run Time 20 Minutes 
b) Equilibration Time : 3 Minutes 
c) Initial Oven Temp. 130�C 
d) Oven Temp. Initial Time 0 Minutes 
e) Rate fCMin) 8"CMin 
f) Final Oven Temp. 260 T 
g) Oven Temp. Finai Time 5 Minutes 
h) Oven Temp. Post Time 5 Minutes 
2 5 
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(C) SEM Acquisition Parameters 
a) Solvent Delay 4 Minutes 
b) eMVolts 1800V 
c) Start Time 4 Minutes 
d) Low Mass 403 m/z 
e) High Mass 406 mJz 
f) No. ofPlot Traces 2 
g) Time Window 20 
h) Piot 杜 1 m/z : Single Ion 403 with Scale : 30000 
i) Plot # 1 m/z : Single Ion 406 with Scale : 30000 
(D) Injection Parameters 
a) Injection Mechanism Auto Liquid Sampler 
b)No. ofAwash 2 
c) No. ofB wash 2 
d) No. of Sample Wash 2 
e) No. of Sample pumps 4 
f) Injector Stroke length 1 
g) Sample Viscosity 0 
h) Mode ofInjection Fast 
i) No. ofApre-Wash 2 
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4.1 Clinical features of subjects 
The elderly subjects with both sexes recruited in this study were divided into 
two main groups : vegetarians and non-vegetarians. The number of vegetarians 
recruited into our study was 145. They were either Taoists or Buddhists and had been 
on vegetarian diet for at least seven years. Among this group, 63 subjects were lacto-
vegetarians with 61 living in old-aged home. The rest of 82 were vegans with 19 living 
in old-aged home. Their overaU age was 78.5 土 7.1 years (mean 土 SD)，ranging from 
60 to 92 years. The total number of non-vegetarians recruited was 393，172 of them 
came from old-aged homes and the rest, 221, from Prince of Wales Hospital (PWH). 
The non-vegetarian subjects from old-aged homes appeared healthy and were self 
ambulatory. The subjects from PWH were patients. The serum cobalamin 
concentrations in some of these hospital patients were previously known to be 
subnormal. The overall age was 79.0 土 6.8 years (mean 土 SD), ranging from 60 to 97 
years. Non-vegetarian subjects from old-aged home had their urinary MMA excretion 
measured but not serum cobalamin. Non-vegetarian subjects from PWH had both their 
serum cobalamin and urinary MMA excretion measured 
4.2 General blood analysis 
The whole blood analysis of the vegetarians, the overaU mean white cell count 
(WBC) was 6.6 土 2.4 x 10^/L, ranging from 4.0 - 9.8 x 10 /^0.. The mean haemoglobin 
was 11.9 土 1.46 gML，ranging from 6.3 to 14.4 g/dL. The mean cell volume was 90.6 
土 8.6 fL, ranging from 64.6 to 113 fL. The reference ranges of these parameters in the 
local population were listed in Table 2. 
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Table 2 Normal reference ranges of complete blood picture in the 
local Chinese population in Hong Kong. 
Test Reference Unit 
parameter range 
Red ceU count 3.7-4.9 x 10 ^^ /L 
Haemoglobin 11.5 -14.3 g/dL 
Haematocrit 0.32 - 0.43 ratio 
MCV 81-97 fL 
MCHC 32 - 35 g/dL 
MCH 27 - 33 pg 
Platelet count 140 -380 x 10 /^L 
WBC 4 - 10 X10 9/L 
MCV: Mean red cell volume; MCHC: Mean cell haemoglobin concentration; 
MCH: Mean cell haemoglobin; WBC: White cell count. 
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In the lacto-vegetarian subjects (total 63), none was iron deficient. 33 had 
normal liver function test ( total protein, albumin, total bilirubin，alkaline phosphatase, 
alanine transaminase, aspartate transaminase and gamma glutamyl transaminase), 31 
with normal renal function test (sodium, potassium, urea and creatinine), 3 with red 
cell haemoglobin level less than 10 gy'dL and 11 with blood platelet count less than 150 
X 10 9/L. In the vegan subjects (total 82), 2 were confirmed as iron deficient. 42 had 
normal liver fiinction test, 42 with normal renal function test, 8 with red cell 
haemoglobin level less than 10 g/dL and 8 with blood platelet count less than 150 X 10 
9/L. The reference ranges for blood biochemistry in the local Chinese population in 
Hong Kong were shown in Table 3 • 
4.3 Serum cobalamin analysis 
In this study, 308 subjects, including 145 vegetarian subjects and 163 non-
vegetarian subjects from PWH, had sera obtained from fasting whole blood specimens 
for cobalamin assay. Of these, 110 (35.7 %) had serum cobalamin concentrations less 
than 120 pmol/L and 10 (3.2 %) had serum cobalamin concentrations greater than 
1000 pmobTL. The serum cobalamin concentration was 198 土 40.8 pmoL/L (mean 土 
SD). ranging from 37 to 1771 pmoLOL (Fig 3). 
Li the 145 vegetarian subjects, the serum cobalamin concentration was 188 土 
40.2 pmolyOL (mean 土 SD)，ranging from 37 to 1331 pmol/L. Among these vegetarians, 
65 (44.8 %) had serum cobalamin concentrations less than 120 pmoLOL and 77 (53.1 
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Table 3 Normal reference ranges of blood biochemistry in the local 
Chinese population in Hong Kong. 
Specimen type Test Reference range Unit 
Plasma sodium 134 - 145 mmol/L 
potassium 3.5 - 5.1 mmoU, 
^ 3 .4 -8 .9 mmoUL 
creatinine 44 - 107 umoi/L 
* 
Totai protein 66 - 81 g ^ 
albumin 36 - 48 g[L 
Total bilirubin 0 - 15 fjimolbl^ 
AJk. phosphatase 40 - 100 IU7L 
SGPT/ALT < 58 KJ/L 
yGT < 100 U/L 
calcium 2.20 - 2.62 mmoLT. 
phosphate 0.82 - 1.40 mmolA. 
Serum ][on 6 - 30 mmobl. 
TEBC 40 - 73 ^moVL 
Ferritin 70 - 625 pmoLOL 
Cobalamin 150 - 700 pmoVL 
Folate 7 - 3 7 pmoLGL 
sTm 0 . 3 - 4 . 0 mRJ/L 
Zinc 9.4 _ 18.4 ^moLGL 
Copper 10.7 - 25.2 ]JimoUL 
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higher than 120 pmol/L. The concentration was 282 土 127 pmol/L (mean 土 SD)， 
ranging from 121 to 1331 pmol/L. 
La the 163 non-vegetarian subjects, the serum cobalamin concentration was 203 
± 35.7 pmoVL (mean 土 SD), ranging from 37 to 1771 pmoVL. Among these non-
vegetarians, 45 (27.6%) had serum cobalamin concentrations less than 120 pmoUL and 
67 (41.1%) less than 150 pmoVL. 118 (72.4%) had serum cobalamin concentration 
higher than 120 pmo^L. The concentration was 234 土 102 pmoL^ (mean 土 SD), 
ranging from 124 to 1771 pmoUL. 
The vegetarian subjects had significantly lower serum cobalamin concentrations 
than the non-vegetarians (unpaired t = 3.47, p < 0.005). There were significantly more 
vegetarians having low serum cobalamin concentrations (< 120 pmol/L) than the non-
vegetarian subjects (Chi-square Test with Yates correction = 9.175, two-sided P value 
< 0.005). 
4.4 Urinary MMA analysis 
4.4.1 Extraction of MMA in urine 
Since MMA is a weak dicarboxylic acid, urine sample was acidified to make 
MMA more protonated and thus more non-polar for effective extraction with organic 
solvents such as diethyl ether or ethyl acetate. 
ln this study, 1000 \jiL of untreated urine was acidified with concentrated 
hydrochloric acid, followed by saturation with sodium chloride and extraction with 
ethyl acetate. Three successive extractions, with 3 mL of ethyl acetate, resulted in a 
recovery ofmore than 90% of urinary MMA. 
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4.4.2 Derivatization 
The rate of derivatization of MMA with N-methyl-N-(tert-
but>ddimethyisilyl)trifiUoroacetarnide (MTBSTFA) depended on temperature. When 
the process was carried out at room temperature, complete silylation of 37.3 nmoles 
MMA in 80 [iOL of MTBSTFA took at least twelve hours. However, at 80°C, the 
reaction time could be shortened to one hour. 
The chemical structure of the tert-butyldimethylsilyl (t-BDMS) derivative of 
MMA was shown in Fig. 4. Fragmentation of t-BDMS-MMA by electron ionization 
resulted in removal of the methyl or tert-butyldimethyl groups. The most dominant ion 
species of the derivatives was m/z 403, For d3-MMA derivatives, the most dominant 
ion species was mIz 406. 
After derivatization with MTBSTFA, the t-BDMS derivative of MMA 
produced in the chromatogram an intense peak of ion m/z 403 and retention time 
14.759 minutes ^"ig 5). The t-BDMS derivative of d3-MMA produced two intense 
peaks of the ion m/z 406 at retention times of 11.583 minutes and 14.736 minutes. The 
peak at l4.736 minutes was the dominant peak and almost overlapped with the ion 
peak of m/z 403 (Fig. 6). The difference in the retention time was 0.025 minute but the 
two peaks were resolvable. The small peak ion at 11.583 min was discarded for 
quantitation. The within-run coefficient of variation of the derivative retention time 
was 0.09% (n=20) and the between-run coefficient of variation was 0.3% (n=20). Such 
good precision suggested that there was insignificant drifting in retention time between 
each run. The possibility ofhaving wrong identification ofion peaks was therefore very 
low. 
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Fig. 4 (a) Structure & (b) mIz values of the tert-butyldimethylsilyl 
derivative of methylmalonic acid and the fragmentation points (Straczek 
J et al, J Chromatogr 1993; 620: 1-7.) 
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Fig. 6 Selected ion chromatogram at m/z 406 and the mass spectrum of 
d3-MMA 
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4.4.3 GC-MS analysis 
(a) Specificity 
Identification of MMA on selected ion monitoring (SJM) was based on the 
retention time, its molecular ion of m/z 403 and the molecular ion at m/z 406 of its 
analog as internal standard, d3-MMA. In the GC programme used in this study, other 
organic compounds bearing similar structures to MMA ( succinic acid, methylsuccinic 
acid, glutaric acid, malonic acid and ethylmalonic acid) had retention times that 
differed significantly from that ofMMA. The ion masses obtained after ionization were 
also different. Hence, the detector signals at the ion peaks m/z 403 and 406 accurately 
represented the amount of the corresponding derivatives in the MS detector. Fig. 7 
illustrated the structures, molecular weights, m/z values and mass spectra for the t-
BDMS derivatives of some common dicarboxylic acids that were found in urine. 
(b) Calibration curve 
The response ratio of m/z 403/406 of increasing amounts ofMMA (0 - 1350 
ng) was studied. A constant quantity of d3-MMA (400 ng) was used. The MMA 
concentrations in the assay mixture ranged from 0 to 40 fim0l7L (Fig. 8). The urinary 
MMA concentrations in aU subjects with or without cobalamin deficiency should be 
within this range. A standard curve was established from the peak-intensity ion ratio 
m/z 403/406 with a linear regression equation y = 0.3209 x + 0.0242 , r = 0.999 (n 
=7), y being the response ratio m/z 403/406 and x being the MMA concentration (Fig. 
9). The curve was regarded as linear from 0 to 17 p.moUL. 
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(c) The lowest limit of detection 
An urine sample with known MMA concentration was diluted with distiUed 
water to obtain a series of samples wkh decreasing endogenous MMA concentrations 
As the MMA concentration became lower, the response ratio approached to a constant 
value 0.098 土 0.013 (n = 20) with a linear equation y = 1.0189x -0.0088, r =0.996; y 
being the measured MMA concentration and x being the expected MMA 
concentration.. The lowest limit of detection was assigned to be 0.124 p,moH. (2 SD 
above the mean) with a signal-to-noise ratio of 5 . Table 4 described the expected 
MMA concentrations with the corresponding measured MMA concentrations in a 
series of diluted urine sample. The data were plotted in Fig. 10. 
(d) Reproducibility 
Two MMA standard solutions at 3.4 and 12.4 p,moL^ and two urine samples 
with endogenous MMA concentrations at 1.13 and 8.23 ^moUL were analysed over a 
three month period. The imprecision of the within-run assay were less than 6.5 % and 
the between-run assay imprecision less than 8.0 % (Tables 5 and 6). 
(e) Recovery 
Recovery of MMA after the whole process of solvent extraction, blow drying 
« 
with nitrogen gas and chromatographic separation were assessed. MMA standard was 
spiked to a urine sample (300 [jJJ) to give three different levels (3.59，8.20 and 13.25 
p,moVL) and were tested in three batches. The results of spike-recoveries of three 
MMA samples were shown in Table 7. They were all close to 90 %. 
4 3 
Table 4. The expected MMA concentrations compared with 
corresponding measured MMA concentrations in a series of diluted 
urine samples. 
Expected fMMA] , Measured [MMA], Percentage difference from 
jimoVL pmo^L expected concentration 
- ^ - ^ — . . . [ 疋 0 
1.28 1.38 +7.8 
0.64 0.68 +6.30 
0.32 0.31 -3.10 
0.19 0.18 -5.30 
0.13 0.10 -23.1 











































































































































































Table 5. The results ofwithin-run analysis of four MMA samples, two 
standards and two urine specimens, n = 20. 
Within Run Std 1 SW2 Urinel Urine 2 ~ " 
Mean 336 ITo L05 8^9 
SD ^51 ^ 0 ^ 0 ^ . 
Range 
(mean± 2.94 -3.78 10.8 - 13.2 0.91 - 1.19 7.87 - 8.91 
2SD) 
%CV 6.26 5.19 6.43 3.10 
PVIMA] : ^oUL 
4 6 
Table 6. The results of between-run analysis of four MMA samples, 
two standards and two urine specimens, n = 20. 
Within Run StTl S t ^ Urine 1 U r i n e 2 ~ " 
Mean ^ 3 E i 1.20 8 ^ 
SD ^ ^ ^ ^ 
Range 
(mean± 2.95 -3.91 10.9 - 14.7 1.00 - 1.40 6.93 -9.21 
2SD) 
% CV 6.90 7.58 7.90 7.03 
PVIMA] : |jmoLl. 
47 
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Table 7. The results of spike-recoveries of three MMA samples 
Low Level Mid Level High Level 
(p.moyL) (p,moLTL) (pjnoLTL) 
Number of 9 9 8 
analysis 
M e a n ± S D 3.59土3.8 8.20土5.4 13.3土1.56 
Mean % ¥ f 3 ^ ^ 
Recovery 
range 89.7 - 105 84.0 - 106 86.4 - 92.7~~" 
(mean 土 2SD) 
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(f) Linearity 
An urine sample with high endogenous MMA concentration (42.8 pimolyX^ was 
diluted with distilled water to give a number of different concentrations covering the 
linear range ofthe standard curve. The MMA in diluted urine sample was then assayed 
by the described GC-MS method. A linear equation with y = 0.3217 x + 0.0217，r = 
1.0 was found, y being the response ratio m/z 403/406 and x being the MMA 
concentration fFig. 11). The calculated slope and intercept (0.3217,0.0217) were close 
to those in the standard calibration curve (0.3209,0.0242). 
(g) Stability 
The concentrations of the BDMS derivatives of MMA of two urine samples 
(3.39 and 10.17 ^imoL^ of endogenous MMA) assayed after storage for periods of27, 
42, 54, 72，96, 120 and 144 hours at ambient room temperature were compared with 
their initial concentrations at time zero. The concentration at the time zero was taken 
as 100 o/o. 
Both urine samples showed similar changes in MMA concentration as a 
function of time (Fig.l2). The percentage change was found to be greater in the sample 
with low MMA concentration. The t-BDMS-MMA was fairly stable for the first 24 
hours with about 8.3 % loss. Aner five days, the ioss was about 20 %. 
4.4.4 Urinary MMA Concentrations 
538 subjects including both vegetarians and non-vegetarians had their urine 
analysis for MMA concentration in this study. The overall urinary MMA concentration 




























































































































































































































































































































































































































concentration was 13.8 ± 3.2 ^rnio^L (mean 土 SD) and for the 393 non-vegetarians, 
9.29 土 4.41 ptmol/L (mean 土 SD). Among the 393 non-vegetarian, the urinary MMA 
concentration of subjects (n = 172) living in old-aged homes was 7.62 土 3.63 \imoVL 
(mean 土 SD) and ofsubjects from PWH (n = 221), 9.49 土 4.49 m^ol>QL (mean 土 SD). 
To express the urinary MMA excretion relative to creatinine, the overall MMA 
excretion was 2.55�土 2.07 ^imoVmmol creatinine (mean�土 SD). For the vegetarians, the 
urinary MMA excretion was 3.35 土 1.46 i^moUmmol creatinine (mean 土 SD)，ranging 
from 0.124 to 66.4 fimol/mmol creatinine, and for all the non-vegetarians, 2.16 土 0.76 
^unolAnmol creatinine (mean 土 SD)，ranging from 0.06 to 149 nmoUmmol creatinine. 
For the non-vegetarians living in old-aged homes, the urinary MMA excretion was 
1.74�土 0.77 ^imob'mmol creatinine (mean�土 SD), ranging from 0.16 to 109 pimoL'mmol 
creatinine. For the non-vegetarians from PWH, the urinary MMA excretion was 2.19�土�
0.66 pimoUmmol creatinine (mean�土 SD)，ranging from 0.06 to 149 jimolAnmol 
creatinine. 
28 (19.3 %) of the vegetarians had urinary MMA excretion greater than 5 
p,moVmmol creatinine. If these subjects were excluded from calculation of the sample 
mean, the urinary MMA excretion would be 1.68 土 0.17 |imol/mmol creatinine (mean 
土 SD)，ranging from 0.96 to 3.38 i^moUmol creatinine. 19 (4.8 %) of the non-
vegetarians had urinary MMA excretion greater than 5 i^moL^mmol creatinine. When 
these subjects were excluded from calculation, the urinary MMA excretion of all the 
non-vegetarians would be 1.46 土 0.35 p.moL^mmol creatinine (mean 土 SD)，ranging 
from 0.06 to 4.94 ^unolAnmol creatinine. The urinary MMA excretion in vegetarians 
‘ 5 2 
was significantly different from that in non-vegetarians (unpaired t = 5.09, p <0.005) 
(Table 8). 
4.5 Relationship between urinary MMA excretion and age 
The coefficient of correlation between age (equal to or greater 60 years in our 
subjects) and urinary MMA concentrations was 0.052. When the subjects were divided 
into age groups: 60-70, 71-80 and 81-90 yrs, there was a mild increase in urinary 
MMA excretion with age (Fig. 13). 
4.6 Relationship between urinary MMA excretion and serum 
cobalamin concentrations 
In this study, 263 (48.9 %) out of the total 538 subjects had their serum 
cobalamin concentrations and urinary MMA excretion collected in the same day, 
including 131 vegetarians and 132 non-vegetarians. 47 (17.9 %) out of the 263 
subjects were found to have urinary MMA excretion greater 5 i^molAnmol creatinine. 
Among these 47 subjects, 38 (80.9 %) had serum cobalamin concentrations less than 
120 pmoLT.. When only the 131 vegetarians were counted, 28 were found to have 
elevated urinary MMA excretion. 24 (85.7 %) out of these 28 vegetarians had serum 
cobalamin concentrations less than 120 pmoUL. When only the 132 non-vegetarians 
were counted, 19 were found to have elevated urinary MMA excretion. 14 (73.7 %) 
out of these 19 non-vegetarians had serum cobalamin concentrations less than 120 
pmol/L. In those subjects with both decreased serum cobalamin concentration and 
increased urinary MMA excretion, the respective coefficient of correlation between 
serum cobalamin concentration and urinary MMA excretion for vegetarians and non-
5 3 
Table 8. Trend of urinary MMA excretion in vegetarians and non-
vegetarians 
Age Statistical Non- Vegetarian Unpaired t 
parameter vegetarian subjects test, 




60 - 70 Number 9 10 p < 0.005 
Mean 土 SD 1.00 土 0.06 1.39 土 0.18 
71-80~~Number W ' 42 p<0 .01 
Mean 土 SD 1.53 土 0.46 1.72 土 0.16 
81 -90 Number 29 33 p < 0.005 
Mean±SD 1.51土0.19 1.68土0.17 
Total Number ^ ^ p<0.005 
Mean 土 SD 1.46 土 0.35 1.68 土 0.17 
py4MA] : p,mol/mmol creatinine 
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vegetarians were -0.25 and -0.16 (both P values > 0.05). No statistically significant 
linear association between serum cobalamin concentration and urinary MMA excretion 
was therefore observed in either group. However, there was a correlation (r = -0.435) 
when the log values were plotted (Fig. 14). The linear regression equation was y = -
0.633x + 1.75，y being log MMA excretion and x being log serum cobalamin 
concentration. The significance of such correlation in the log value was unclear. The 
relationship between urinary MMA excretion and serum cobaiamin concentrations in 





















































































































































































































































































































Table 9. Distribution of subjects according to their urinary MMA 
excretion and serum cobalamin status 
No, ofSubjects 
Cbl concentration & Vegetarian Non-vegetarian 
urinary MMA excretion n = 131 n =132 
Cbl < 120 
MMA > 5 24 (18.3%) 14 (10.6%) 
Cbl < 120 
MMA < 5 33 (25.2%) 18 (13.6%) 
Cbl > 120 “ 
MMA< 5 70 (53.4%) 95 (72.0%) � 
Cbi > 120 一 
MMA>5 ‘ 4(3.1%) 5(3.8%) 
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5.1 Serum cobalamin analysis 
The serum cobalamin concentrations in the elderly subjects in this study were 
not normally distributed OFig. 3). Some subjects had very high serum cobalamin 
concentrations. They might have been taking vitamin tablets containing cobalamin 
although they did not reveal it to our clinician during physical examination. 
In the literature, there was no general agreement on the serum cobalamin 
concentration for cobalamin deficiency. Values such as 120 pmol7L and 148 pmol/L 
had been proposed as the cut-off value of cobalamin deficiency [20,21]. In this study, if 
150 instead of 120 pmo^L was chosen as the cut-off value, about 10 % more subjects 
would be considered to be cobalamin deficient in both the vegetarians and non-
vegetarians. It was noted that the percentage of subjects with serum cobalamin 
concentration less than 120 pmoUL was higher in vegetarians (44.8 %) than in non-
vegetarians (27.6 %). If 150 pmol/L was the cut-off value, again there would be more 
vegetarians (53.1 %) than non-vegetarians (41.1 %) being considered as cobalamin 
deficient. 
5.2 Urinary MMA analysis 
5.2.1 Extraction ofMMA in urine 
Since the MMA derivative was unstable in aqueous layer, MMA must first be 
extracted with an organic solvent from urine sample before derivatization. We found 
ethyl acetate to be a suitable solvent for efficient MMA extraction from a urine sample. 
However, the disadvantage was that ethyl acetate evaporated slowly even in the 
presence of a blowing stream of nitrogen gas. Usually two hours were required just to 
blow dry the ethyl acetate extract prior to derivatization. This was time consuming. 
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5.2.2 Derivatization 
Derivatization in the GC-MS technique had three important functions. It made 
the analyte more volatile, increased the efficiency of chromatographic elution and 
improved the differentiation of mass fragments from low molecular weight mass 
fragments by increasing their molecular weight. Rasmussen et al developed a technique 
using dicyclohexyl esters as the derivatives [53]. However, Straczek et al discovered 
an interfering peak at the d3-MMA with this derivative [52]. Straczek supported the 
use ofMTBSTFA because the t-BDMS derivatives ofMMA produced a highly intense 
and sharp base peak at mJz 403 in their spectra. In this study, we found the preparation 
oft-BDMS derivatives efficient and reliable and requiring no special laboratory facility. 
The only precaution, as for many other chemical derivatization process, was that the 
reaction mixture must be kept dry [51]. 
5.2.3 GC-MS analysis 
The calculated m/z 403/406 ratios were proportional to the MMA 
concentrations up to 17 \xmoVL in the injection mixture. Then, the curve became 
flattened as the MMA concentrations increased further. This meant that the mIz ratio 
did not increase proportionally at too high MMA concentration. For urine samples 
containing concentration higher than 17 p,molA., they were diluted before sample 
treatment. Any estimated MMA concentration greater than this value was assayed with 
lesser urine. 
The lowest limit of detection was defined as the lowest concentration ofMMA 
that could be detected accurately and precisely by a particular method of analysis. By 
6 3 
\ 
the same principle, the detection limit ofMMA concentration reported by Matchar et 
aI was 0.85 .^moUL [22]. In our method, the detection limit o fMMA concentration 
was lower (0.124 p,moyL). Since the reference range of urinary MMA concentration 
for spot urine sample determined by MarceU et al [51] was 2.5 - 59.7 [imoUL, our 
method could differentiate a wide range of urinary MMA excretion. 
In this method, reproducibility depended on the extraction techniques and 
performance of the GC-MS equipment. The extraction procedure was efficient and 
acceptable in this study. The mass spectrometer was calibrated evety working day to 
ensure consistent performance. 
The recovery at low MMA concentration was better than at high MMA 
concentration. This observation was in agreement with the outcome of the response 
ratio (m/z 403/406) at MMA concentrations higher than 17 ^mol/L beyond which the 
calibration curve became non-linear and flattened. 
The linearity in the response ratio (nVz 403/406) against MMA concentrations 
was further tested by determining MMA concentrations in serial samples prepared 
from dilution ofan urine specimen containing high MMA concentration. These samples 
were treated exactly in the same way as standard MMA samples prior to GC-MS 
analysis. In this study, the linearity equation (y = 0.3217x +0.0217, r = 1.00) was 
similar to that of the standard calibration curve (y�二 0.3209x + 0.0242, r = 0.999). 
Therefore, the range of the standard calibration curve for MMA from 0.12 to 17 
pimol/L was linear. 
The abundance of the t-BDMS derivatives of MMA started to decrease after 
one day of storage. We therefore recommend derivatized MMA to be injected into the 
GC-MS system for analysis on the same day of preparation. In this study, we have fully 
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evaluated the sample preparation and GC-MS analysis procedure for urinary MMA 
quantitation. The analytical performance is good with acceptable precision, recovery 
and linearity. This procedure is easy to cany out and produces reHable results, and can 
be adopted in any clinical laboratory equipment with a GC-MS system for routine 
urinary MMA analysis. 
5.2.4 Urinary MMA concentrations 
The frequency distribution of urinary MMA concentrations in our subjects was 
not symmetrically bell-shaped. It was negatively skewed. Data were treated with 
logarithm transformation. 
Measurement of MMA in 24-hour urine should be a better measure of MMA 
excretion. However, in practice, 24-hour collection of urine is difficult, especially for 
elderly subjects. There is no guarantee of a complete collection. In one study, a highly 
significant positive correlation (r�二 0.99，P <0.0005, n = 35) between the concentration 
ofMMA relative to creatinine in urine and the urinary MMA excretion rate was found 
by Rasmussen et al [54]. Urinary MMA excretion in moming fasting urine expressed 
with respect to creatinine should provide a reliable measure. 
The mean urina^ MMA excretion of the Hong Kong Chinese elderly subjects 
in this study fell within the reference range reported by Marcell et al [51], 0.78 - 3.68 
p,mol/mmol creatinine. If 5 i^molAnmol creatinine was used as the cut-off value of 
urinary MMA excretion proposed by Norman et al and Matchar et al [21,22], then 47 
(8.7 %) out of total 538 subjects would have elevated urinary MMA excretion and 
thus considered as cobalamin deficient. Among them, 28 (19.3 %) of vegetarians and 
19 (4.8 %) of non-vegetarians would be classified as cobalamin deficient. Our result 
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from non-vegetarians was more similar to that reported by Norman et al [21] in an 
9 
elderly screening study. The elderly subjects in their study were non-vegetarians as 
their living facilities served regular nutritious meals [17]. 
5.3 Relationship between urinary MMA excretion and age 
There was a mild trend that the urinary MMA excretion in our subjects 
• 
increased with age above 60. One possible reason was that fundic atrophic gastritis 
increased with age in elderly population studied by Krasinski et al [46]. 
Norman et al [21] reported a sex difference in urinary MMA excretion. 
Unfortunately, there were insufficient data to study the association between urinary 
MMA excretion and sex in elderly. 
5.4 Relationship between urinary MMA excretion and serum 
cobalamin concentrations 
The coefficient of correlation between low serum cobalamin concentration and 
high urinary MMA excretion was low. This is not surprisingly because serum 
cobalamin and MMA are from two different components in the body, serum cobalamin 
being extracellular and MMA being intracellular. The pathological cause of increased 
urinary MMA excretion is inadequate tissue store of cobalamin. The tissue deficiency 
of cobalamin must be preceded by low serum cobalamin. There might be a time lag 
between the occurrence of low serum cobalamin concentration and the manifestation 
of increased urinary MMA excretion. The duration of this time lag might depends on 
the severity of the cobalamin deficiency of the subjects. Therefore, sampling time for 
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urinary MMA measurement could lead to misinterpretation of the cobalamin status of 
the subject. 
This study supported the belief that the measurement of urinary MMA 
excretion was more diagnostic than serum cobalamin for cobalamin deficiency in the 
tissue. We found a lower percentage of subjects with increased urinary MMA 
excretion than with low serum cobalamin concentration (less than 120 pmoLT.). Our 
results were consistent with those of a elderly screening study conducted by Norman et 
al [21]. They found that about 5 % of the 809 elderly individuals over age 65 had 
urinary MMA excretion greater than 5 i^moVmmol creatinine and among these 
subjects, 51 o/o had serum cobalamin concentrations less than 120 pmol/L. Almost all 
the subjects having high urinary MMA excretion had clinical features compatible with 
cobalamin deficiency while only a small proportion of subjects having low serum 
cobalamin showed signs and features of cobalamin deficiency. Furthermore, serum 
cobalamin has been shown to be an insensitive and non-specific marker for tissue 
cobalamin deficiency in a number of studies [25,27,59]. 
When all our subjects were classified according to their serum cobalamin 
concentrations and urinary MMA excretion, four groups could be derived: 1. low 
serum cobalamin and high urinary MMA; 2. low serum cobalamin and normal urinary 
MMA; 3. high serum cobalamin and normal urinary MMA; 4. normal serum cobalamin 
and high urinary MMA. A study by Matchar [22] also gave a similar distribution 
pattem between urinary MMA concentrations and serum cobalamin status. Subjects in 
group 1 were most likely cobalamin deficient. Subjects in group 2 might not be 
cobalamin deficient but had low serum cobalamin concentrations. Group 3 included 
almost aU cobalamin non-deficient subjects. Lindenbaum et al [17] and Rasmussen et al 
[24] found that some patients with neuropsychiatric abnormalities had serum 
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cobalamin concentrations higher than 150 pmol/L. So, group 4 might include subjects 
with cobalamin deficiency. 
5.5 Relationship between urinary MMA excretion and diet 
In this study, the respective prevalence of cobalamin deficiency in the 
vegetarians and non-vegetarians were 19.3 % and 4.8 % based on urinary MMA 
excretion less than 5 p,moUmmol creatinine. The percentage of cobalamin deficiency 
was nearly four folds in vegetarian elderly than in non-vegetarian elderly. Urinary 
MMA excretion in the vegetarians (3.35 土 1.46 ^moL^mmol creatinine) was 
significantly higher than in the non-vegetarian (2.25 土 1.04 pimol/mmol creatinine). 
Diet might be a factor affecting the urinary MMA concentration. 14.5 % of elderly 
screened by Lindenbaum et al was cobalamin deficient while Norman et al observed 
about 5 % of cobalamin deficient elderly [12,21]. The difference might be due to the 
nutritional status or eating habit of the subjects recruited in their studies. 
We have assessed urinary MMA excretion in all our subjects. Many of them 
were definitely cobalamin deficient. As expected, there was no significant correlation 
between urinary MMA excretion and serum cobalamin concentration. All of our 
subjects are to be followed up and those suspected to be cobalamin deficient are given 
cobalamin supplements. Urine and serum samples will be collected after several months 
to assess their cobalamin status. Their clinical features will also be assessed in details. 
Whether the urine MMA secretion should be used as a biochemical index for 
cobalamin deficiency will be confirmed by them. 
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6. Conclusions 
• 
(1) Screening for cobalamin deficiency in elderly by measuring the urinary MMA 
concentration using GC-MS technique was a possible alternative to serum cobalamin 
assay. Owing to the specificity and sensitivity of GC-MS technique, urinary MMA 
could be measured accurately and precisely. 
(2) The distribution pattem of urinary MMA excretion in the elderly population of 
Hong Kong Chinese was consistent with that of the Caucasians. 
(3) The percentage of elevated urinary MMA excretion was higher in vegetarians 
than in non-vegetarians. Diet was therefore a possible causative factor of cobalamin 
deficiency among the elderly. 
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